Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey smitter, hope all is well. Removing oneself from Ihub is probably the best thing one can do for their health. I try to keep my visits short and sweet, but sometimes spend too much time here.
Notice None mention CareClix Holdings
due to the difficulty in accounting for the disposition of an existing subsidiary
Notice Scott and Greg Arms not involved.
That data is fake. Use FINRA or the OTCMarkets data which is fed from FINRA.
I think only like 30k or 90k were vested at this time. Another portion vests in a year, and then a year after that I believe.
You can confirm in the form 4.
I'll pick up more. Quiet times doesn't mean the company is just sitting on their asses.
Updates in the near future will help us, just have to get through these sellers.
I don't know man lol. I've been in plenty of jobs where people leave really quick. Maybe it just wasn't a good fit. Maybe something better came up. Maybe there are family issues.
Maybe, based on the below she decided she'd rather just focus on other things...
"Prior to her retirement, Ms. Hanigan was the President of Reynolds American Innovation Company"
I think opinions here are a bit outlandish.
From what I'm seeing with some other tickers, filings are taking much longer than ever expected. Back in February auditors told one company they would be done end of March. There was 1 quarter filed in April, and still waiting on the rest.
I'm not surprised things haven't been filed yet, but I can understand everyone's aggravation considering we are on the greys and there is no transparency at this time.
Everyone will have to make their own decisions on how to move forward. I am holding.
Traders giving up their shares on the cheap.
It's obviously legacy. The share counts that converted to unrestricted match directly to two of the legacy holders down to the share. Since then, nothing that was issued on a restricted basis converted to unrestricted easily.
I went line by line and listed out every share given since Niraj took over and there are a few gaps that could be shares from them converting, but the vast majority has to be legacy.
But, what is management supposed to say?
"Hey guys, just wanted to let you know that the shares hitting the market isn't us".
I don't think there is anything to say. It's something they can not control. It doesn't change the forward looking events of the company. They tell us about the FDA, because that has an impact on the business. They release updates on revenue projections and new distribution contracts and agreements because those all have an impact on the business.
The unrestricted shares is technically meaningless. It has a short term affect on the share price if shares get added or removed, but at the end of the day, your market cap or earnings per share is not affected by shares being added/removed (to the unrestricted count)
The issue is our lack of institutional investors which is because we're on the OTC. We trade a few hundred grand a day, which is pocket change for institutions. When the day comes where we trade $10M, the unrestricted will prove to be meaningless.
You got me. But do you know why I posted that?
If you've followed me that intently you'd know it was more of a ruse to get him to say something than an actual shot at him/management.
I knew the shares were not from current management. If you look at my older posts I show you exactly where the first 6 million or so shares come from. I've also posted proof more recently showing that almost all of the shares management issued were restricted and there is no way the unrestricted increase was from them, but rather from legacy shares.
At the end of the day we speak with our ownership and buying/selling decisions. I am holding and I am buying more.
Excuse you? I was not bashing management when it was trading in the .20s-.30s. If you remember correctly I was buying the whole time and I was trying to be the voice of reason for many people here who couldn't keep their eye on the prize.
Was I disappointed in management? No, I was disappointed in traders who clearly had no clue what they were doing. Unfortunately it's the same story now, with traders who can't add 4 quarters of revenues, or traders who don't understand what it means for a company to add 11 new markets to distribute to, or traders who don't understand what it means when an insider buys $300k worth of shares in the open market, or when traders don't understand the difference between a small R/S to up list and an R/S to continue dumping shares into the market.
Click on the word "Quarterly".
Add up those values. Or just go to the 10K for 2020 and add in the 10Q for 2021.
Not sure what you are trying to say about before or after listing, these are their financials. You are a perfect example of the traders we have on this stock. No idea what they are talking about.
I don't know if it's a reading comprehension issue or addition but I said 1 year, which is 12 months, which is 4 quarters, which is over $100M.
I have to say, the most annoying thing about OTC traders is the lack of long term vision and patience. There is more patience on things like ENZC, which in my opinion is your typical OTC bs company, than KAVL who continues to operate at a level higher than almost the entire exchange.
Don't get me wrong, I flip stocks, I have short term holds, etc. But there is a difference between short term flips and something like KAVL. That is where the disconnect is.
KAVL went from $0 to $100M in 12 months. PLEASE, find me more OTC companies that have done that.
With profits comes positive cash flow.
With positive cash flow comes investments in new products, companies, patents, etc.
With more products under control, the more profits are generated, the higher positive cash flow, the more investment opportunities arise, etc.
This takes time. During this time, we will see wild fluctuations in price because OTC players aren't investors, they are traders. They look for hype and they have no problem selling on the bid to chase something else. They don't care about revenues and profits or growth opportunities.
Isn't it odd that so many OTC traders go around complaining on different boards about scams when a ticker goes up in price? It's because they missed out. They are butt hurt that they aren't making money and it's easier to put doubt in others than to fine tune their trading to become profitable. How many have you seen a poster say nonsense about a stock on the way up, and then buy it on the bounce and suddenly start cheering? Plenty I'm sure, and those are the type of people we have trading KAVL.
That is the main reason we aren't priced higher. There is a mentality issue with OTC traders due to most of our experience with OTC scams and pumps. But you must ask yourself; How many of these OTC companies have audited financials like KAVL, displaying 9 figure profits for the year?
At some point a larger percent of our shares will be in strong hands. If we have an R/S, I think it'll be sooner rather than later. If we wait to up list organically, I think it will take much longer to churn through bad traders, but it will eventually happen.
High promises, low delivery. Poor execution.
Niraj has been very quiet lately. I don't think it's a bad thing at all, just wondering if he's waiting for NASD to start releasing news, or after the Q.
Finally CNGT getting some love!
Okay, thanks for your input.
That's a good read. I enjoyed it.
I like reading the comments. Seems some folks don't understand how to use financials to determine a valuation and think this is being pumped.
I don't think the unrestricted share count has changed much, so that leads me to believe most shares are still locked up.
if they announce NO R/S,. this will go to 10.00 in a week! kavl
If you say so.
These shares for a buck or slightly over are going to be very nice buys in a few days/weeks/months.
I feel like something is going on behind the scenes.
I'm not sure if it's the company buying or some other entity, but I've seen 50k+ blocks smacked on the ask. I've seen large bids not get touched, and obviously everyday new highs.
I think financials are due out the middle of May, I hope something in there explains this increase in price/activity.
Since the cat is out of the bag and they have to file, wouldn't it be nice if they took us to the NASD? On the OTC they aren't ever going to get the same recognition as other regional/small time airlines so insiders might as well see the real value of the company.
Questions/Answers were added to the website...
https://kaivalbrands.com/investor-relations/#faq
Haha thank you!
Nice buy. Moody plays are hot hot hot.
Really? That's not right, you are not blocked haha. I would never block you.
Their financials have always been late, and anyone who has been here since the beginning should remember that they missed "deadlines" almost every time.
Heck, we were told in November to expect filings in December and we didn't get the 10K until February. Who's fault is that? They clearly were working on them otherwise we would have never seen it.
Everyone likes to think something nefarious is going on, yet, this has been their track record. Do I like it? No! Does anyone like it? I doubt it, but that doesn't change the fact that this isn't something new.
It's not as if they were on time every quarter, then they got suspended and completely stopped filing anything. Just seems to me too many people owning too many shares demanding information from a company on the OTCs.
Things will happen, when they happen. You start putting timelines on your investment activities and you're bound to get upset.
I thought someone was going to take out that 25k shares? lol
Crappy didn't you sell a few weeks ago? Can't stay away I see.
They did amazingly while others didn't.
The only other airline with a positive EPS for the last 12 months was MESA, and they currently trade at 12x PE.
That would put us in the $5-$6 range. Looking forward to the next quarterly due out in 2 weeks.
Think it's due mid June, but they can release anytime before then.
Love HRBR. Quietly moving to new 52w highs.
Should be over $2 in the short term.
On March 30, 2020, the Company’s board of directors adopted a stock repurchase program pursuant to which the Company may initially repurchase up to $1.0 million of shares of its common stock from time to time during the first calendar month of the program, subject to an automatic increase of $1.0 million per calendar month thereafter.
What is interesting about this is on March 1, 2021 we saw a sudden surge in volume and price. We gapped up pretty significantly and we hovered above .60 the entire time (the close pre-gap was .50) as if someone/entity was holding us above.
Fast forward to April 1, 2021, and we see a surge in volume 3x what we saw on March 1st. It took the price from $.70 to over $1.00. Again, since then the price has been held above $1.10 for the entire month.
I'm looking forward to see if May 3, 2021 generates a strong burst of volume and increase in share price like the last 2 months.
I will always be trading OTCs. You can't beat the gains. Options come close, but you have time decay, so not only do you need to be right on timing, but also the pricing.
With that said, there are just some stocks that don't do well on OTC, and that is real companies, generating real revenues, and real cash flow/profits. (Don't confuse pink sheets and OTCQB stocks with foreign stocks with 5 letters ending in an F. Those are completely different)
ENZ_C - valued at $400M and was trading over a billion dollars earlier in the year. It's being valued like this because of hype and unreal expectations. They claim to have $21M in assets with ~18.7M labeled "Investment in Subsidiaries", but no revenues. Their O/S went from 959M to 1.5B to 2.8B.
HMB_L - valued at over $1.2Billion and at one point almost $6Billion. They have a pretty clean balance sheet with over a million in cash, but that's it. No revenue or profits.
How are these two examples worth more than KAVL? I'm not saying those two plays won't go up further, because when hype and awareness is involved, along with momentum and millions of dollars traded each day, you just never know what will happen.
Berdboy might be right, maybe when the OTC traders finally sees a $75M or $100M quarter then we'll go up, but if the OTC is buying the two plays above with no regard to cash flows and revenues then why should we expect to receive anything substantial? If the OTC hangs on to every word of CEOs "pumping" their company, then why aren't people buying the re-affirmed $400M in revenue?
On the OTC we invest in the potential future of the ticker. On the OTCs, revenue doesn't matter, profits don't matter, it's all about the story and the hype associated with the stock.
Hence why SOLI ran to over $1.30 while on the greys before any company details emerged.
As we know, SOLI has been dead money for over a year. If/when SOLI files their delinquent quarterlies, relists on the pinks, it'll be a great story. People see how TDOC/AMWL are doing, see that there is an OTC stock in the telemed space, see that it's gotten off the greys TWO times, which as you stated has NEVER happened, and will say, wow they must be legit.
Given the small unrestricted share count, we could rocket north pretty easily.
That's what I'm here for.
You just summed up nearly all OTC companies, give or take a few traits.
Every OTC stock starts out as a nothing. You can flip and make money when everything is discovered, or you could be in early, when no one wants to own it. I've made the most money on trades that were in the "who would want to own this" stage.
We invest in what we expect/anticipate to be a winner. Why in the world would you invest in something you knew wouldn't be a winner?
Did you think PTAH was going to be a "real winner"? When you bought KMAG did you think it was a "real winner"? Turns out they weren't winners, but that doesn't mean you shouldn't have invested.
None of what you posted scares me and if someone happens to be spooked by your comments, then they don't know how the OTC works. Until I see CareClix Inc is no longer in business, I don't think you can say this is a loser, or a winner. I think we see filings before we see CareClix is out of business and if I'm wrong, oh well, good thing I diversify my investments and already made up for any potential loss here.
No guarantee but less likely to happen.
I know what you're saying, you're sticking with the R/S is bad, no one will want to buy us after an R/S, etc.
What I'm saying is, no one is going to take us serious on the OTC.
I can almost guarantee you would not be here if it weren't for your low average. We have how many new individuals posting here? No one wants to pay dollars for an OTC company. I probably wouldn't buy either, because if I'm looking for my next trade/investment, chances are it's not going to be a $1 company. I know how the OTC works, and I know why KAVL isn't getting any attention, just like I know why HRBR isn't getting much attention. There is no hype, there is no excitement for the new investors like there is for custodian plays, or reverse mergers.
We own a great company, but we trade on a garbage exchange where people don't value fundamentals and growth.
I keep hearing, be patient, let's just up list organically. I don't think it happens. I don't think we generate enough interest on the OTC to overcome the minimum bid, and sustain it regardless of how good the next few quarters are.
I've said it before, the OTC is not for a company like KAVL. Look at HRBR, they have better fundamentals than KAVL and still trades at a 2x EPS and almost half of it's book value.
OTC DOES NOT REWARD QUALITY COMPANIES. If that means we need to do a 1:5 R/S, then bring it on. I don't care if it takes us months to reach a more realistic valuation on the NASD, I just rather be there, then have to deal with 1 person, selling 100k shares and taking us down 20% because there is no bid support.
$87,000,000 traded today.
KAVL traded $115,000.
But here's the thing berdboy, we do not have plenty of buyers. If we had plenty of buyers we would do more than $115k volume.